About NexPlasmaGen
NexPlasmaGen is a company based in Montreal (Canada) founded in 2008 by Valerie Leveille.. NexPlasmaGen has raised $795 thousand across 1 funding round from investors including National Research Council Canada, Mitacs and Aligo Innovation. NexPlasmaGen offers products and services including Cold Plasma Technology. NexPlasmaGen operates in a competitive market with competitors including Galil Medical, Vessi Medical, Sanarus, CAPS Medical and Hrain Biotechnology, among others.
- Headquarter Montreal, Canada
- Founders Valerie Leveille
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Nexplasmagen Incorporée
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$795 K (USD)
in 1 rounds
-
Latest Funding Round
$795 K (USD), Seed
Aug 13, 2018
-
Investors
National Research Council Canada
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NexPlasmaGen
NexPlasmaGen offers a comprehensive portfolio of products and services, including Cold Plasma Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology to reduce cancer recurrence in breast surgery
Funding Insights of NexPlasmaGen
NexPlasmaGen has successfully raised a total of $795K through 1 strategic funding round. The most recent funding activity was a Seed round of $795 thousand completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $795,000
-
First Round
First Round
(13 Aug 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Seed - NexPlasmaGen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NexPlasmaGen
NexPlasmaGen has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include National Research Council Canada, Mitacs and Aligo Innovation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
MEDTEQ+ is focused on accelerating health technology innovation.
|
Founded Year | Domain | Location | |
|
A foundation focused on economic development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NexPlasmaGen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NexPlasmaGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nexplasmagen Comparisons
Competitors of NexPlasmaGen
NexPlasmaGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Galil Medical, Vessi Medical, Sanarus, CAPS Medical and Hrain Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A platform offering an online slot game for entertainment.
|
|
| domain | founded_year | HQ Location |
Provider of method for treating bladder cancer
|
|
| domain | founded_year | HQ Location |
Breast cryoablation therapy for tumors is provided by Sanarus.
|
|
| domain | founded_year | HQ Location |
Cold atmospheric plasma technology is developed for tumor treatment.
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for tumor immunotherapy solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NexPlasmaGen
When was NexPlasmaGen founded?
NexPlasmaGen was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Where is NexPlasmaGen located?
NexPlasmaGen is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Is NexPlasmaGen a funded company?
NexPlasmaGen is a funded company, having raised a total of $795K across 1 funding round to date. The company's 1st funding round was a Seed of $795K, raised on Aug 13, 2018.
What does NexPlasmaGen do?
NexPlasmaGen was founded in 2008 in Montreal, Canada, within the medical device sector focused on oncology. A patented cold plasma device has been developed by the company to deliver targeted plasma species matched to breast cancer types. Cellular oxidative stress is induced by these species to eliminate cancer cells. Operations center on advancing this technology for clinical applications in cancer therapy.
Who are the top competitors of NexPlasmaGen?
NexPlasmaGen's top competitors include Galil Medical, Vessi Medical and CAPS Medical.
What products or services does NexPlasmaGen offer?
NexPlasmaGen offers Cold Plasma Technology.
Who are NexPlasmaGen's investors?
NexPlasmaGen has 4 investors. Key investors include National Research Council Canada, Mitacs, Aligo Innovation, and MEDTEQ+.